Deficiency of IL-22–binding protein enhances the ability of the gut microbiota to protect against enteric pathogens
Proceedings of the National Academy of Sciences · 07.05.2024 · 121 (19)
DOI: 10.1073/pnas.2321836121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 30.04.2024. Verfasst von José L Fachi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Citrobacter rodentium, Mice, Knockout, Clostridioides difficile. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases, Pew Charitable Trusts.
Abstract (Originalsprache)
Interleukin 22 (IL-22) promotes intestinal barrier integrity, stimulating epithelial cells to enact defense mechanisms against enteric infections, including the production of antimicrobial peptides. IL-22 binding protein (IL-22BP) is a soluble decoy encoded by the Il22ra2 gene that decreases IL-22 bioavailability, attenuating IL-22 signaling. The impact of IL-22BP on gut microbiota composition and functioning is poorly understood. We found that Il22ra2 –/– mice are better protected against Clostridioides difficile and Citrobacter rodentium infections. This protection relied on IL-22-induced antimicrobial mechanisms before the infection occurred, rather than during the infection itself. Indeed, the gut microbiota of Il22ra2 –/– mice mitigated infection of wild-type (WT) mice when transferred via cohousing or by cecal microbiota transplantation. Indicator species analysis of WT and Il22ra2 –/– mice with and without cohousing disclosed that IL22BP deficiency yields a gut bacterial composition distinct from that of WT mice. Manipulation of dietary fiber content, measurements of intestinal short-chain fatty acids and oral treatment with acetate disclosed that resistance to C. difficile infection is related to increased production of acetate by Il22ra2 –/– -associated microbiota. Together, these findings suggest that IL-22BP represents a potential therapeutic target for those at risk for or with already manifest infection with this and perhaps other enteropathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110.
- Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305.
- Clinical Biomarkers and Diagnostics, Amgen Inc., South San Francisco, CA 94080.
- Edison Family Center for Genome Sciences and Systems Biology, and the Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St. Louis, MO 63110.
- Department of Genetics, Evolution, Microbiology, and Immunology, Institute of Biology, University of Campinas, Campinas, Sao Paulo 13083-862, Brazil.
ORCID-Profile: Susan Gilfillan, Marina Cella, Marco Colonna
Förderung
- NIDDK NIH HHS
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases
- Pew Charitable Trusts
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Fachi, J. L., Di Luccia, B., Gilfillan, S., Chang, H. W., Song, C., Cheng, J., Cella, M., Vinolo, M. A., Gordon, J. I., & Colonna, M. (2024). Deficiency of IL-22–binding protein enhances the ability of the gut microbiota to protect against enteric pathogens. Proceedings of the National Academy of Sciences, 121(19). https://doi.org/10.1073/pnas.2321836121
Vancouver
Fachi JL, Di Luccia B, Gilfillan S, Chang HW, Song C, Cheng J, et al. Deficiency of IL-22–binding protein enhances the ability of the gut microbiota to protect against enteric pathogens. Proceedings of the National Academy of Sciences. 2024;121(19). doi:10.1073/pnas.2321836121
BibTeX
@article{Fachi2024,
author = {Fachi, José L and Di Luccia, Blanda and Gilfillan, Susan and Chang, Hao-Wei and Song, Christina and Cheng, Jiye and Cella, Marina and Vinolo, Marco Aurelio and Gordon, Jeffrey I and Colonna, Marco},
title = {Deficiency of IL-22–binding protein enhances the ability of the gut microbiota to protect against enteric pathogens},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {19},
doi = {10.1073/pnas.2321836121}
}
EUVIMED